NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $37.70 -1.24 (-3.18%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$37.64▼$39.1050-Day Range$37.46▼$47.2052-Week Range$37.35▼$60.99Volume42,238 shsAverage Volume78,361 shsMarket Capitalization$718.19 millionP/E Ratio11.74Dividend YieldN/APrice Target$38.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get USANA Health Sciences alerts: Email Address USANA Health Sciences MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside0.8% Upside$38.00 Price TargetShort InterestHealthy2.64% of Float Sold ShortDividend StrengthN/ASustainability-2.08Upright™ Environmental ScoreNews Sentiment1.21Based on 3 Articles This WeekInsider TradingSelling Shares$1.20 M Sold Last QuarterProj. Earnings Growth8.80%From $2.50 to $2.72 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.23 out of 5 starsMedical Sector298th out of 910 stocksMedicinals & Botanicals Industry4th out of 12 stocks 1.0 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 1 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.64% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 4.59%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 3.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 29.02% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Direct selling of nutritional products through representatives", "Direct selling of dietary supplements through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -2.08. Previous Next 2.3 News and Social Media Coverage News SentimentUSANA Health Sciences has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for USANA Health Sciences this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for USNA on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,204,486.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 8.80% in the coming year, from $2.50 to $2.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 11.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 130.36.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 11.74, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 132.22.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about USANA Health Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the Markets"Doomsday indicator” flashing for the first time since the Great Depression...It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...Click here to discover how Wall Street insiders are quietly preparing for a market crash >>> About USANA Health Sciences Stock (NYSE:USNA)USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More USNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart USNA Stock News HeadlinesAugust 16, 2024 | insidertrades.comPaul A. Jones Sells 6,266 Shares of USANA Health Sciences, Inc. (NYSE:USNA) StockAugust 9, 2024 | insidertrades.comGilbert A. Fuller Sells 674 Shares of USANA Health Sciences, Inc. (NYSE:USNA) StockSeptember 7, 2024 | Behind the Markets (Ad)"Doomsday indicator” flashing for the first time since the Great Depression...It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...September 3, 2024 | prnewswire.comUSANA Executive Chairman Kevin Guest Celebrates Entrepreneurs in Today's Business WorldAugust 29, 2024 | finance.yahoo.comUSANA Achieves HR Asia's "Best Companies to Work For" Title for Three Consecutive YearsAugust 19, 2024 | prnewswire.comUSANA Launches New, Innovative Skincare and Protein Products Resurfacing Serum and Whey Protein Isolate up the game for USANAAugust 15, 2024 | finance.yahoo.comInsider Sale: Chief People Officer Paul Jones Sells 6,266 Shares of Usana Health Sciences Inc (USNA)August 12, 2024 | uk.finance.yahoo.comReflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)September 7, 2024 | Behind the Markets (Ad)"Doomsday indicator” flashing for the first time since the Great Depression...It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...August 1, 2024 | prnewswire.comUSANA Executive Chairman Kevin Guest Shares 7 Steps to Soar Like OlympiansJuly 25, 2024 | finance.yahoo.comWhy USANA (USNA) Shares Are Plunging TodayJuly 25, 2024 | gurufocus.comQ2 2024 USANA Health Sciences Inc Earnings Call TranscriptJuly 23, 2024 | markets.businessinsider.comUSANA Health Sciences is about to announce its earnings — here's what to expectJuly 23, 2024 | marketwatch.comUSANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS GuidanceJuly 23, 2024 | markets.businessinsider.comUSANA Health Sciences Q2 Profit Retreats, Misses EstimatesJuly 23, 2024 | theglobeandmail.comUSANA (NYSE:USNA) Misses Q2 Revenue EstimatesJuly 23, 2024 | businesswire.comUSANA Health Sciences Reports Second Quarter 2024 ResultsJuly 22, 2024 | msn.comUSANA Health Sciences Q2 2024 Earnings PreviewSee More Headlines Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/23/2024Today9/07/2024Next Earnings (Estimated)10/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$38.00 High Stock Price Target$38.00 Low Stock Price Target$38.00 Potential Upside/Downside+0.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$3.21 Trailing P/E Ratio11.74 Forward P/E Ratio15.08 P/E Growth1.32Net Income$63.79 million Net Margins6.29% Pretax Margin10.79% Return on Equity11.13% Return on Assets8.83% Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio3.44 Sales & Book Value Annual Sales$921.01 million Price / Sales0.78 Cash Flow$4.19 per share Price / Cash Flow8.99 Book Value$26.88 per share Price / Book1.40Miscellaneous Outstanding Shares19,050,000Free Float18,988,000Market Cap$718.19 million OptionableOptionable Beta0.90 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Kevin G. Guest (Age 61)Executive Chairman Comp: $1.08MMr. Jim Brown (Age 55)CEO & President Comp: $910.73kMr. G. Douglas Hekking (Age 54)Chief Financial Officer Comp: $638.34kMr. Walter Noot (Age 58)Chief Operating Officer Comp: $623.77kMr. P. Joshua Foukas (Age 48)Chief Legal Officer, General Counsel & Corporate Secretary Comp: $561.28kMr. Daniel A. Macuga Jr. (Age 54)Chief Communications & Marketing Officer Comp: $563kDr. Myron W. Wentz (Age 83)Founder & Chairman Emeritus Dr. John CuomoExecutive Director of Product Development & TechnologyDr. Robert A. Sinnott M.N.S. (Age 59)Ph.D., Chief Scientific Officer Mr. Patrique RichardsExecutive Director of Investor Relations & Business DevelopmentMore ExecutivesKey CompetitorsHerbalifeNYSE:HLFNu Skin EnterprisesNYSE:NUSNature's Sunshine ProductsNASDAQ:NATRMedifastNYSE:MEDVeruNASDAQ:VERUView All CompetitorsInsiders & InstitutionsDeerfield Management Company L.P. Series CBought 22,251 shares on 8/15/2024Ownership: 0.156%AQR Capital Management LLCSold 3,293 shares on 8/15/2024Ownership: 0.060%Public Sector Pension Investment BoardBought 1,242 shares on 8/14/2024Ownership: 0.127%Cubist Systematic Strategies LLCBought 7,735 shares on 8/14/2024Ownership: 0.062%Marshall Wace LLPBought 11,602 shares on 8/14/2024Ownership: 0.061%View All Insider TransactionsView All Institutional Transactions USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $53.60 at the beginning of 2024. Since then, USNA stock has decreased by 29.7% and is now trading at $37.70. View the best growth stocks for 2024 here. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings data on Tuesday, July, 23rd. The company reported $0.54 EPS for the quarter, missing analysts' consensus estimates of $0.65 by $0.11. The business had revenue of $212.87 million for the quarter, compared to analysts' expectations of $218.64 million. USANA Health Sciences had a trailing twelve-month return on equity of 11.13% and a net margin of 6.29%. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are USANA Health Sciences' major shareholders? Top institutional investors of USANA Health Sciences include Renaissance Technologies LLC (6.19%), Pzena Investment Management LLC (5.13%), Dimensional Fund Advisors LP (3.59%) and Pacer Advisors Inc. (2.45%). Insiders that own company stock include Myron W Wentz, Kevin Guest, David Mulham Mulham, Joshua Foukas, John Turman Fleming, Frederic J Winssinger, Xia Ding, Brent Neidig, Daniel A Macuga, Paul A Jones, Robert A Sinnott, Gilbert A Fuller, Walter Noot, G Doug Iiekking and Jim Brown. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX) and AbbVie (ABBV). This page (NYSE:USNA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredHere’s A Painful Truth and 100% Fact About The Stocks You’re HoldingCharles Payne here, and I want to let you in on an uncomfortable truth that long term investors and retirees n...Unstoppable Prosperity | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.